Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP
capital market auditor for a period of two years, starting from 8 October 2019. The SEC has also advised KPMG to conduct a root cause analysis on Patamavan’s performance deficiencies and lay out a
ที่ กบร No. Kor Bor Ror. 032/2017 November 9, 2017 President The Stock Exchange of Thailand Re : Increase of the investment proportion in the ordinary shares of Pattaya Manufacturing Co., Ltd. Dear
1 No. LorBor. 11/2019 May 13, 2019 Re: Joint Venture in Pulp Mold Manufacturing Project Attn.: President The Stock Exchange of Thailand Kaset Thai International Sugar Corporation Public Company
which must be corrected, and the root cause analysis for such errors. The study also proposes recommendations on important factors which play an important role in the accurate preparation of financial
an aim to study the root causes of such issues and propose possible solutions to the problem. To make it work, we need all stakeholders to cooperate. We encourage stakeholders in the financial
after year, audit firms should continue to improve their auditing techniques along with policies and methods, and also take steps to develop a root cause analysis to have better understanding on factors
. OCMSET/6201/006 January 30, 2019 Re: Management Plan after Discontinuation of Business of Manufacturing Accessories and Faucet Products, the Disposition of Assets Relating to Such Business. Attn
ที่ กบร No. Kor Bor Ror. 032/2017 November 9, 2017 President The Stock Exchange of Thailand Re : Increase of the investment proportion in the ordinary shares of Pattaya Manufacturing Co., Ltd
. OCMSET/6201/006 January 30, 2019 Re: The Disposition of Assets Relating to the Business of Manufacturing Accessories and Faucet Products which the Board of Directors’ Meeting No. 9/2018 Has Approved to